Endpoints News 13. Feb. 2026 PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna
Endpoints News 12. Feb. 2026 BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins